Literature DB >> 2751158

Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro.

G H Ayars1, L C Altman, M M McManus, J M Agosti, C Baker, D L Luchtel, D A Loegering, G J Gleich.   

Abstract

Tissue injury is observed in allergic and nonallergic eosinophilic rhinitis, but the mechanism of this injury is unclear. Because eosinophils are prominent in biopsy specimens in these conditions, we hypothesized that they may participate in the injury process. Initially, we developed techniques to isolate and purify human nasal epithelial cells from turbinate biopsies to use as target cells for eosinophil granule products. Primary cultures from explants were characterized by electron microscopy and indirect immunofluorescence with a panel of primary monoclonal and polyclonal antibodies. These studies revealed the homogeneity of the cells and confirmed their epithelial nature. Cultured nasal epithelial cells were then exposed to either purified human eosinophil peroxidase, bromide, and glucose plus glucose oxidase, as a continuous source of hydrogen peroxide, or eosinophil major basic protein. Neither eosinophil peroxidase alone nor glucose plus glucose oxidase in the absence of eosinophil peroxidase were injurious, but the combined addition of eosinophil peroxidase, glucose/glucose oxidase, and bromide produced marked target cell lysis. This effect was time- and eosinophil peroxidase dose-dependent. Catalase and azide significantly inhibited the lysis of these cells, suggesting the eosinophil peroxidase-catalyzed products of halide oxidation mediated this form of injury. The addition of purified human eosinophil major basic protein also caused dose- and time-dependent lysis of the nasal epithelial cells but required longer incubation periods to effect injury. We hypothesize that the eosinophil peroxidase-hydrogen peroxide-halide system and major basic protein may injure the nasal epithelium in inflammatory conditions such as allergic and nonallergic eosinophilic rhinitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751158     DOI: 10.1164/ajrccm/140.1.125

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

Review 1.  Nasal polyposis, eosinophil dominated inflammation, and allergy.

Authors:  N Mygind; R Dahl; C Bachert
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  In vitro modulation of the eosinophil-dependent enhancement of the permeability of the bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Palmitic acid-rich oils with and without interesterification lower postprandial lipemia and increase atherogenic lipoproteins compared with a MUFA-rich oil: A randomized controlled trial.

Authors:  Charlotte E Mills; Scott V Harding; Mariam Bapir; Giuseppina Mandalari; Louise J Salt; Robert Gray; Barbara A Fielding; Peter J Wilde; Wendy L Hall; Sarah E Berry
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 7.045

4.  Stimulated eosinophils and proteinases augment the transepithelial flux of albumin in bovine bronchial mucosa.

Authors:  C A Herbert; D Edwards; J R Boot; C Robinson
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

Review 5.  Changing roles of eosinophils in health and disease.

Authors:  Glenn T Furuta; F Dan Atkins; Nancy A Lee; James J Lee
Journal:  Ann Allergy Asthma Immunol       Date:  2014-05-01       Impact factor: 6.347

Review 6.  Allergic rhinitis in children : diagnosis and management strategies.

Authors:  William E Berger
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Non-allergic rhinitis: a case report and review.

Authors:  Cyrus H Nozad; L Madison Michael; D Betty Lew; Christie F Michael
Journal:  Clin Mol Allergy       Date:  2010-02-03

8.  Asthma: eosinophil disease, mast cell disease, or both?

Authors:  Peter Bradding
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

9.  A comparison of the effects of polyarginine and stimulated eosinophils on the responsiveness of the bovine isovolumic bronchial segment preparation.

Authors:  T Omari; M P Sparrow; M K Church; S T Holgate; C Robinson
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.

Authors:  S R White; M E Strek; G V Kulp; S M Spaethe; R A Burch; S P Neeley; A R Leff
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.